Shevan Silva
0 sources
Shevan Silva
Summary
Shevan Silva is a human[1]. They worked as a researcher[2].
Key Facts
- Shevan Silva worked as a researcher[2].
- Shevan Silva was educated at University of Auckland[3].
- Shevan Silva's doctoral advisor was Adam Patterson[4].
- Shevan Silva's doctoral advisor was Jeff Smaill[5].
- Shevan Silva's instance of is recorded as human[6].
- Shevan Silva's ORCID iD is recorded as 0000-0002-9942-1897[7].
- Shevan Silva earned the academic degree of Doctor of Philosophy[8].
- Shevan Silva's academic thesis is recorded as Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer[9].
- Shevan Silva's academic thesis is recorded as The design and characterization of aldo-keto reductase 1C3 (AKR1C3) prodrugs for acute myeloid leukaemia[10].
- Shevan Silva studied under Jack Flanagan[11].
- Shevan Silva studied under Adam Patterson[12].
- Shevan Silva studied under Jeff Smaill[13].
- Shevan Silva's on focus list of Wikimedia project is recorded as NZThesisProject[14].
- Shevan Silva's OpenAlex ID is recorded as A5051692752[15].
Body
Education
Shevan Silva was educated at University of Auckland[3]. Doctoral advisors include Adam Patterson[4], a researcher[16] and Jeff Smaill[5], a researcher[17], of New Zealand[18]. They earned the academic degree of Doctor of Philosophy[8]. Studied under Jack Flanagan[11], a biochemist[19]; Adam Patterson[12], a researcher[20]; and Jeff Smaill[13], a researcher[21], of New Zealand[22].
Career and Affiliations
Shevan Silva's professions included researcher[2].
FAQs
What did Shevan Silva do for work?
Shevan Silva worked as researcher[2].
Where did Shevan Silva go to school?
Shevan Silva was educated at University of Auckland[3].